|Articles|May 1, 2002

New brimonidine formulation has improved tolerability profile

Brimonidine tartrate 0.2% (Alphagan, Allergan) has been shown to confer neuroprotection in a number of ocular injury models when applied topically or systemically.1

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME